Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia

The prognostic significance of bone marrow minimal residual disease (MRD) in pediatric patients with acute myeloid leukemia (AML) is well characterized, but the impact of blood MRD is not known. We, therefore, used flow cytometric assessment of leukemia-specific immunophenotypes to measure levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Karol, Seth E., Coustan-Smith, Elaine, Pounds, Stanley, Wang, Lei, Inaba, Hiroto, Ribeiro, Raul C., Pui, Ching-Hon, Klco, Jeffery M., Rubnitz, Jeffrey E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365945/
https://www.ncbi.nlm.nih.gov/pubmed/37058475
http://dx.doi.org/10.1182/bloodadvances.2022009534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365945/
https://www.ncbi.nlm.nih.gov/pubmed/37058475
http://dx.doi.org/10.1182/bloodadvances.2022009534

Ejemplares similares